Insider Transactions in Q1 2025 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2025
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,068
-4.75%
|
$32,040
$30.93 P/Share
|
|
Feb 12
2025
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,047
+8.34%
|
-
|
|
Feb 12
2025
|
Stephen Hoge President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,771
-0.19%
|
$83,130
$30.93 P/Share
|
|
Feb 12
2025
|
Stephen Hoge President |
BUY
Grant, award, or other acquisition
|
Direct |
5,734
+0.39%
|
-
|
|
Feb 12
2025
|
Stephane Bancel Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,400
-0.12%
|
$192,000
$30.93 P/Share
|
|
Feb 12
2025
|
Stephane Bancel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,233
+0.24%
|
-
|
|
Feb 07
2025
|
Stephen Hoge President |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-0.02%
|
$9,273
$33.61 P/Share
|
|
Feb 07
2025
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
523
+0.04%
|
-
|
|
Jan 03
2025
|
James M Mock Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
780
-6.23%
|
$32,760
$42.0 P/Share
|
|
Jan 03
2025
|
James M Mock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,453
+10.4%
|
-
|